Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Richter, WO' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 67 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Richter, WO
      Applications of fatty acid derivatives and antioxidants in dietary lipids

      EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY
    2. Otto, C; Ritter, MM; Richter, WO; Minkenberg, R; Schwandt, P
      Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks

      METABOLISM-CLINICAL AND EXPERIMENTAL
    3. Otto, C; Richter, WO; Schwandt, P
      Contribution of fibrinogen and lipoproteins to plasma viscosity in hypercholesterolemia and hypertriglyceridemia: Evaluation by selective depletion of low-density lipoproteins or fibrinogen

      METABOLISM-CLINICAL AND EXPERIMENTAL
    4. Richter, WO
      The DGF's network of experts in health and fat

      FETT-LIPID
    5. Schwandt, P; Geiss, HC; Ritter, MM; Ublacker, C; Parhofer, KG; Otto, C; Laubach, E; Donner, MG; Haas, GM; Richter, WO
      The prevention education program (PEP), a prospective study of the efficacy of family-oriented life style modification in the reduction of cardiovascular risk and disease: Design and baseline data

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    6. Donner, MG; Parhofer, KG; Richter, WO; Schwandt, P
      Low-density lipoprotein (LDL) oxidizability before and after LDL apheresis

      METABOLISM-CLINICAL AND EXPERIMENTAL
    7. OTTO C; PARHOFER KG; RITTER MM; RICHTER WO; SCHWANDT P
      EFFECTS OF ACIPIMOX ON HEMORHEOLOGY AND PLASMA-LIPOPROTEINS IN PATIENTS WITH MIXED HYPERLIPOPROTEINEMIA

      British journal of clinical pharmacology
    8. RICHTER WO; SCHWANDT P
      LIPID-LOWERING THERAPY AFTER MYOCARDIAL-INFARCTION - THE BAVARIAN CHOLESTEROL SCREENING PROJECT

      JAMA, the journal of the American Medical Association
    9. RICHTER WO; DONNER MG; HOFLING B; SCHWANDT P
      LONG-TERM EFFECT OF LOW-DENSITY-LIPOPROTEIN APHERESIS ON PLASMA-LIPOPROTEINS AND CORONARY HEART-DISEASE IN NATIVE VESSELS AND CORONARY-BYPASS IN SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

      Metabolism, clinical and experimental
    10. DONNER MG; KLEIN GK; MATHES PB; SCHWANDT P; RICHTER WO
      PLASMA TOTAL HOMOCYSTEINE LEVELS IN PATIENTS WITH EARLY-ONSET CORONARY HEART-DISEASE AND A LOW CARDIOVASCULAR RISK PROFILE

      Metabolism, clinical and experimental
    11. RICHTER WO; DONNER MG; SELMAIER A; HILLER E; SCHWANDT P
      EFFICACY AND SAFETY OF IMMUNOGLOBULIN APHERESIS

      ASAIO journal
    12. MIDDEKE M; RICHTER WO; SCHWANDT P; HOLZGREVE H
      THE EFFECTS OF ANTIHYPERTENSIVE COMBINATION THERAPY ON LIPID AND GLUCOSE-METABOLISM - HYDROCHLOROTHIAZIDE PLUS SOTALOL VS HYDROCHLOROTHIAZIDE PLUS CAPTOPRIL

      International journal of clinical pharmacology and therapeutics
    13. RICHTER WO; DONNER MG; SCHWANDT P
      ELIMINATION OF ISLET-CELL ANTIBODIES AND GLUTAMIC-ACID DECARBOXYLASE ANTIBODIES-II IN A PATIENT WITH NEWLY-DIAGNOSED INSULIN-DEPENDENT DIABETES-MELLITUS

      Journal of clinical apheresis
    14. DONNER MG; RICHTER WO; SCHWANDT P
      LONG-TERM FOLLOW-UP OF CAROTID ATHEROSCLEROSIS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA UNDER LDL APHERESIS TREATMENT

      Journal of clinical apheresis
    15. OTTO C; PSCHIERER V; SOENNICHSEN AC; SCHWANDT P; RICHTER WO
      POSTPRANDIAL HEMORRHEOLOGY AND APOLIPOPROTEIN-B METABOLISM IN PATIENTS WITH FAMILIAL HYPERTRIGLYCERIDEMIA

      Metabolism, clinical and experimental
    16. DONNER MG; RICHTER WO; SCHWANDT P
      ELIMINATION OF DIFFERENT LDL SUBFRACTIONS BY LDL APHERESIS

      Atherosclerosis
    17. OTTO C; RICHTER WO; SCHWANDT P
      CONTRIBUTION OF FIBRINOGEN TO ELEVATED PLASMA VISCOSITY IN PATIENTS WITH FAMILIAL HYPERTRIGLYCERIDEMIA

      Atherosclerosis
    18. RITTER MM; GEWITSCH J; RICHTER WO; GEISS HC; WILDNER MW; SCHWANDT P
      APOLIPOPROTEIN-E POLYMORPHISM HAS NO INDEPENDENT EFFECT ON PLASMA-LEVELS OF LIPOPROTEIN(A)

      Atherosclerosis
    19. BRAUTIGAM R; BRAUTIGAM C; LORENZ R; RICHTER WO; ENGELMANN B
      ARACHIDONIC-ACID OF PLATELET PHOSPHOLIPIDS IS DECREASED AFTER EXTRACORPOREAL REMOVAL OF PLASMA LOW-DENSITY LIPOPROTEINS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA

      Atherosclerosis
    20. RITTER MM; RICHTER WO; OTTO C; DONNER M; SCHWANDT P
      AWARENESS AND THERAPY OF HYPERCHOLESTEROLEMIA BEFORE AND AFTER 1991 -RESULTS OF THE BAVARIAN CHOLESTEROL SCREENING PROJECT

      Atherosclerosis
    21. OTTO C; SCHWANDT P; RICHTER WO
      CONTRIBUTION OF PLASMA CONSTITUENTS TO PLASMA VISCOSITY - IN-VITRO EVALUATION BY COLUMN DEPLETION OF LOW-DENSITY-LIPOPROTEINS, FIBRINOGEN, OR IMMUNOGLOBULINS

      Atherosclerosis
    22. RICHTER WO; GEISS HC; ALEKSIC S; SCHWANDT P
      CARDIAC AUTONOMIC NERVE FUNCTION AND INSULIN SENSITIVITY IN OBESE SUBJECTS

      International journal of obesity
    23. GEISS HC; RITTER MM; RICHTER WO; SCHWANDT P; ZACHOVAL R
      LOW LIPOPROTEIN (A) LEVELS DURING ACUTE VIRAL-HEPATITIS

      Hepatology
    24. PARHOFER KG; RICHTER WO; SCHWANDT P
      DRUG-THERAPY OF SEVERE HYPERCHOLESTEROLEMIA IN PATIENTS WITH CORONARY-ARTERY DISEASE

      Artificial organs
    25. RICHTER WO; DONNER MG; SCHWANDT P
      SHORT-TERM AND LONG-TERM EFFECTS ON SERUM-LIPOPROTEINS BY 3 DIFFERENTTECHNIQUES OF APHERESIS

      Artificial organs
    26. OTTO C; RITTER MM; SOENNICHSEN AC; SCHWANDT P; RICHTER WO
      EFFECTS OF N-3 FATTY-ACIDS AND FENOFIBRATE ON LIPID AND HEMORRHEOLOGICAL PARAMETERS IN FAMILIAL DYSBETALIPOPROTEINEMIA AND FAMILIAL HYPERTRIGLYCERIDEMIA

      Metabolism, clinical and experimental
    27. PARHOFER KG; BARRETT PHR; DEMANT T; RICHTER WO; SCHWANDT P
      EFFECTS OF WEEKLY LDL-APHERESIS ON METABOLIC PARAMETERS OF APOLIPOPROTEIN-B IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

      Journal of lipid research
    28. BRAUTIGAM C; ENGELMANN B; REISS D; REINHARDT U; THIERY J; RICHTER WO; BROSCHE T
      PLASMALOGEN PHOSPHOLIPIDS IN PLASMA-LIPOPROTEINS OF NORMOLIPIDEMIC DONORS AND PATIENTS WITH HYPERCHOLESTEROLEMIA TREATED BY LDL APHERESIS

      Atherosclerosis
    29. RICHTER WO; GEISS HC; SONNICHSEN AC; SCHWANDT P
      TREATMENT OF SEVERE HYPERCHOLESTEROLEMIA WITH A COMBINATION OF BETA-SITOSTEROL AND LOVASTATIN

      Current therapeutic research
    30. OTTO C; DONNER MG; SCHWANDT P; RICHTER WO
      SEASONAL-VARIATIONS OF HEMORHEOLOGICAL AND LIPID PARAMETERS IN MIDDLE-AGED HEALTHY-SUBJECTS

      Clinica chimica acta
    31. PARHOFER KG; BARRETT PHR; DEMANT T; RICHTER WO; SCHWANDT P
      EFFECT OF APHERESIS ON KINETIC-PARAMETERS OF APOLIPOPROTEIN-B METABOLISM IN FAMILIAL HYPERCHOLESTEROLEMIA

      Circulation
    32. SONNICHSEN AC; OTTO C; RICHTER WO; SCHWANDT P
      CAUSAL LINK BETWEEN LOW-CHOLESTEROL AND CANCER IS UNLIKELY

      BMJ. British medical journal
    33. RITTER MM; RICHTER WO; SCHWANDT P
      WHAT IS THE PLACE OF LDL-APHERESIS IN THE PREVENTION OF CORONARY HEART-DISEASE

      NMCD. Nutrition Metabolism and Cardiovascular Diseases
    34. RICHTER WO; SONNICHSEN AC; SCHWANDT P
      RESULTS AND EFFICACY OF PUBLIC SCREENING FOR HYPERCHOLESTEROLEMIA - THE BAVARIAN CHOLESTEROL SCREENING PROJECT

      Journal of clinical epidemiology
    35. RICHTER WO; DONNER MG; SCHWANDT P
      DEXFENFLURAMINE INHIBITS CATECHOLAMINE STIMULATED IN-VITRO LIPOLYSIS IN HUMAN FAT-CELLS

      International journal of obesity
    36. EICHHORN P; SCHWANDT P; RICHTER WO
      PROOPIOMELANOCORTICOTROPIN (POMC) PEPTIDES AND LIPOPROTEIN-LIPASE ACTIVITY IN-VITRO

      Peptides
    37. RICHTER WO; SCHWANDT P
      LOW-DENSITY-LIPOPROTEIN APHERESIS

      Lancet
    38. SCHWANDT P; RICHTER WO
      DRUG-TREATMENT OF HYPERCHOLESTEROLEMIA

      Wiener Klinische Wochenschrift
    39. RICHTER WO
      DIETARY-TREATMENT OF HYPERCHOLESTEROLEMIA

      Wiener Klinische Wochenschrift
    40. OTTO C; RICHTER WO
      HEMOSTATIC FACTORS AND THE RISK OF MYOCARDIAL-INFARCTION

      The New England journal of medicine
    41. PSCHIERER V; RICHTER WO; SCHWANDT P
      PRIMARY CHYLOMICRONEMIA IN PATIENTS WITH SEVERE FAMILIAL HYPERTRIGLYCERIDEMIA RESPONDS TO LONG-TERM TREATMENT WITH (N-3) FATTY-ACIDS

      The Journal of nutrition
    42. OTTO C; RICHTER WO
      34-YEAR-OLD PATIENT WITH CHRONIC RECURREN T SEVERE ABDOMINAL-PAIN

      Der Internist
    43. KULSCHAR R; ENGELMANN B; BRAUTIGAM C; DUHM J; THIERY J; RICHTER WO
      FAST TRANSMISSION OF ALTERATIONS IN PLASMA PHOSPHATIDYLCHOLINE SPHINGOMYELIN RATIO AND LYSE PHOSPHATIDYLCHOLINE LEVELS INTO CHANGES OF RED-BLOOD-CELL MEMBRANE PHOSPHOLIPID-COMPOSITION AFTER LOW-DENSITY-LIPOPROTEIN APHERESIS/

      European journal of clinical investigation
    44. SCHWANDT P; RICHTER WO; SONNICHSEN AC
      LOWERING HIGH PLASMA-CHOLESTEROL LEVELS IS NOT DANGEROUS

      Archives of internal medicine
    45. OTTO C; RICHTER WO
      SYNDROME OF INAPPROPRIATE ANTIDIURETIC-HORMONE SECRETION INDUCED BY DIFFERENT DRUGS

      The Annals of pharmacotherapy
    46. SCHWANDT P; RICHTER WO
      SCREENING FOR SECONDARY CAUSES OF HYPERLIPIDEMIA IN GENERAL-PRACTICE - HISTORY SHOULD BE CONSIDERED BEFORE SCREENING

      BMJ. British medical journal
    47. RITTER MM; RICHTER WO; MOHRLE W; SCHWANDT P
      THE UNFAVORABLE LIPID CONSTELLATION OF OBESITY IS CORRELATED WITH IMPAIRED INSULIN SENSITIVITY

      NMCD. Nutrition Metabolism and Cardiovascular Diseases
    48. RICHTER WO
      IMPROVED PROGNOSIS BY TREATMENT OF LIPOPR OTEIN DISORDERS - RESULTS AND CONCLUSIONS FROM INTERVENTION TRIALS

      Fett
    49. RITTER MM; RICHTER WO; SCHWANDT P
      ELIMINATION OF LIPOPROTEIN(A) BY APHERESIS USING POLYCLONAL APO-B 100ANTIBODIES

      Journal of clinical apheresis
    50. RITTER MM; GEISS HC; RICHTER WO; SCHWANDT P
      LIPOPROTEIN(A) AND RISK OF MYOCARDIAL-INFARCTION

      JAMA, the journal of the American Medical Association
    51. RITTER MM; GEISS HC; RICHTER WO; SCHWANDT P
      LIPOPROTEIN(A) CONCENTRATIONS AND PHENOTYPES IN CONTROLS AND PATIENTSWITH HYPERCHOLESTEROLEMIA OR HYPERTRIGLYCERIDEMIA

      Metabolism, clinical and experimental
    52. PSCHIERER V; RITTER MM; RICHTER WO
      PROGRESSIVE CORONARY HEART-DISEASE IN A F AMILY WITHOUT THE CLASSICALRISK-FACTORS

      Der Internist
    53. SCHUFFWERNER P; GOHLKE H; BARTMANN U; BAGGIO G; CORTI MC; DINSENBACHER A; EISENHAUER T; GRUTZMACHER P; KELLER C; KETTNER U; KLEOPHAS W; KOSTER W; OLBRICHT CJ; RICHTER WO; SEIDEL D; SCHOPPENTHAU M; SCHLIERF G; MARBURGER C; ZOLLNER N; SUHLER K; SCHWANDT P; SCHOTTENFELDNAOR J; LESCHKE M; GRIES FA; GOHLKE W; BESTEHORN HP; BRAUNAGEL K; BAUER M; HORL WH; JUST H; MEINERTZ T; SCHOLLMEYER P; WIELAND H; PREVIATO L; CREPALDI G; ARMSTRONG VW; SCHOEPPE W; MUCHE R; REXER H; HILGERS R
      THE HELP-LDL-APHERESIS MULTICENTER STUDY, AN ANGIOGRAPHICALLY ASSESSED TRIAL ON THE ROLE OF LDL-APHERESIS IN THE SECONDARY PREVENTION OF CORONARY HEART-DISEASE .2. FINAL EVALUATION OF THE EFFECT OF REGULAR TREATMENT ON LDL-CHOLESTEROL PLASMA-CONCENTRATIONS AND THE COURSE OF CORONARY HEART-DISEASE

      European journal of clinical investigation
    54. PARHOFER KG; BARRETT PHR; AGUILARSALINAS CA; RICHTER WO; SCHONFELD G
      THE LENGTH OF TRUNCATED APOLIPOPROTEIN-B CORRELATES LINEARLY WITH ITSIN-VIVO SECRETION RATE

      Circulation
    55. PARHOFER KG; BARRETT PHR; AGUILARSALINAS CA; RICHTER WO; SCHONFELD G
      THE LENGTH OF TRUNCATED APOLIPOPROTEIN-B CORRELATES LINEARLY WITH ITSIN-VIVO SECRETION RATE

      Circulation
    56. KORTH R; ZIMMERMANN K; RICHTER WO
      LIPOPROTEIN-ASSOCIATED PAF (LA-PAF) WAS FOUND IN WASHED HUMAN PLATELETS AND MONOCYTE MACROPHAGE-LIKE U937 CELLS/

      Chemistry and physics of lipids
    57. ENGELMANN B; BRAUTIGAM C; KULSCHAR R; DUHM J; PRENNER E; HERMETTER A; RICHTER WO; THIERY J; SEIDEL D
      REVERSIBLE REDUCTION OF PHOSPHOLIPID BOUND ARACHIDONIC-ACID AFTER LOW-DENSITY-LIPOPROTEIN APHERESIS - EVIDENCE FOR RAPID INCORPORATION OF PLASMALOGEN PHOSPHATIDYLETHANOLAMINE INTO THE RED-BLOOD-CELL MEMBRANE

      Biochimica et biophysica acta. Biomembranes
    58. OTTO C; RICHTER WO
      UNILATERAL GYNECOMASTIA INDUCED BY TREATMENT WITH DILTIAZEM

      Archives of internal medicine
    59. SCHWANDT P; RICHTER WO
      EFFECTS OF LDL APHERESIS ON CORONARY HEART-DISEASE

      Annales de medecine interne
    60. JACOB BG; RICHTER WO; SCHWANDT P
      THERAPY OF SEVERE FAMILIAL HETEROZYGOUS HYPERCHOLESTEROLEMIA BY LOW-DENSITY-LIPOPROTEIN APHERESIS WITH IMMUNOADSORPTION - EFFECTS OF THE ADDITION OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE INHIBITORS TO THERAPY

      The Clinical investigator
    61. SONNICHSEN AC; RITTER MM; MOHRLE W; RICHTER WO; SCHWANDT P
      THE WAIST-TO-HIP RATIO CORRECTED FOR BODY-MASS INDEX IS RELATED TO SERUM TRIGLYCERIDES AND HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL BUT NOT TO PARAMETERS OF GLUCOSE-METABOLISM IN HEALTHY PREMENOPAUSAL WOMEN

      The Clinical investigator
    62. VONRITTER C; NIEMEYER A; LANGE V; MOHRLE W; RICHTER WO; VONMEYER L; BRANDL H; DELPOZO R; JUNGST D
      INDOMETHACIN DECREASES VISCOSITY OF GALLBLADDER BILE IN PATIENTS WITHCHOLESTEROL GALLSTONE DISEASE

      The Clinical investigator
    63. ARENDT RM; WILBERTLAMPEN U; HEUCKE L; SCHMOECKEL M; SUHLER K; RICHTER WO
      INCREASED ENDOTHELIN PLASMA-CONCENTRATIONS IN PATIENTS WITH CORONARY-ARTERY DISEASE OR HYPERLIPOPROTEINEMIA WITHOUT CORONARY EVENTS

      Research in experimental medicine
    64. DUMOULIN A; MULLERDERLICH J; BIEBER F; RICHTER WO; FREI U; MULLER R; SPAETHE R
      ANTIBODY-BASED IMMUNOADSORPTION AS A THERAPEUTIC MEANS

      Blood purification
    65. JACOB BG; RICHTER WO; SCHWANDT P
      LONG-TERM TREATMENT (2 YEARS) WITH THE HMG COA REDUCTASE INHIBITORS LOVASTATIN OR PRAVASTATIN IN COMBINATION WITH CHOLESTYRAMINE IN PATIENTS WITH SEVERE PRIMARY HYPERCHOLESTEROLEMIA

      Journal of cardiovascular pharmacology
    66. HABERL R; RICHTER WO; WINDSTETTER H; BAURIEDEL G; BABIC R
      RECURRENT TRANSITORY ISCHEMIC ATTACKS

      Der Internist
    67. GEISS HC; RITTER MM; RICHTER WO; SCHWANDT P
      DETERMINATION OF APOLIPOPROTEIN(A) ISOFORMS BY SODIUM DODECYL-SULFATEPOLYACRYLAMIDE ELECTROPHORESIS AND IMMUNOBLOTTING

      Analytical biochemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/02/20 alle ore 09:20:16